Tiotropium bromide as adjunct therapy in children with asthma: a clinical experience.
Zainab RidhaMarc-Antoine BédardAnna SmyrnovaOlivier DrouinAniela PruteanuSandrine EssouriFrancine M DucharmePublished in: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology (2021)
In children with severe asthma on Step 4 or 5, tiotropium bromide was primarily used as substitute, rather than additional, adjunct therapy to improve asthma control, alleviate adverse effects, and/or to improve lung function. The latter two indications, combined with its perceived effectiveness in children with prominent moist cough, also suggest additional indications of tiotropium to be formally explored.